A Multitumor CME/MOC-, NCPD- and ACPE-Accredited Educational Conference Developed in Partnership with Florida Cancer Specialists & Research Institute
Note from the Moderator
This coming April 23rd marks the return of our annual National General Medical Oncology Summit. To include community perspectives, we are pleased to be partnering again with Florida Cancer Specialists & Research Institute for this one-of-a-kind offering that will span 3 days and feature a stellar multidisciplinary faculty panel of clinical investigators and a unique blend of short didactic presentations, lively moderated panel discussions and dedicated Q&A sessions. The conference’s educational design and the topics that will be discussed offer interested clinicians access to the in-depth perspectives of some of the top minds in the field regarding significant new datasets, promising treatment strategies and key interdisciplinary management considerations in the care of patients with cancer. We hope you will join us in sunny Florida for a learning experience unlike any other out there.
Program Schedule — Eastern Time
Friday to Sunday, April 23 to 25, 2027
Location
The Ritz-Carlton Orlando, Grande Lakes
4012 Central Florida Parkway
Orlando, Florida
Hotel Phone: (407) 206-2400
Meeting Room
Ritz Carlton Ballroom (Salons I-III) — Lobby Level
Room Reservations
A special discounted room rate of $429 per night (plus applicable tax and discounted resort fee) is available to conference attendees at The Ritz-Carlton Orlando, Grande Lakes. Please see the Location tab for details.
No registration fee. Preregistration is required for in-person attendance in Orlando as seating is limited.
Moderator
Neil Love
MD
Research To Practice
Miami, Florida
Faculty to be announced.
Join us from Friday, April 23 to Sunday, April 25, 2027.
Preliminary Agenda
A detailed agenda and speaker information will be made available in the coming months. Times and schedule are subject to change.
Friday, April 23rd
6:30 PM – 7:00 PM Welcome Reception
7:00 PM – 9:00 PM Keynote Session
Saturday, April 24th
7:00 AM – 7:45 AM Breakfast
7:45 AM – 12:30 PM Morning General Session
12:30 PM – 1:15 PM Lunch
1:15 PM – 5:30 PM Afternoon Breakout Sessions
Sunday, April 25th
7:00 AM – 7:45 AM Breakfast
7:45 AM – 12:15 PM Morning General Session
12:15 PM – 1:00 PM Lunch
1:00 PM – 3:30 PM Afternoon General Session
Target Audience
This activity has been designed to meet the educational needs of medical oncologists, hematologists, hematology-oncology fellows, surgeons, radiation oncologists, pharmacists, nurse practitioners, clinical nurse specialists and other healthcare professionals involved in the treatment of cancer.
Learning Objectives
To be announced.
CE Credit
CME, ABIM MOC, ABS and ACPE credit information will be given to each participant as part of the meeting course materials.
NCPD Credit
To obtain a certificate of completion and receive credit for this event, nurses must attend the entire activity and return a completed Educational Assessment and Credit Form. A credit form link will be given to each participant as part of the meeting course materials.
CME Accreditation Statement
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Credit Designation Statement
To be announced.
American Board of Internal Medicine (ABIM) — Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component and a post-test, enables the participant to earn Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Please note, this program has been specifically designed for the following ABIM specialties: medical oncology and hematology.
American Board of Surgery (ABS) — Continuous Certification (CC)
Successful completion of this CME activity, which includes participation in the evaluation component and a post-test, enables the learner to earn Medical Knowledge MOC points toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABS credit.
Please note, this program has been specifically designed for the following ABS practice area: complex general surgical oncology.
NCPD Accreditation Statement
Research To Practice is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Number of Contact Hours Awarded
To be announced.
ONCC/Individual Learning Needs Assessment (ILNA) Certification Information
This activity will be remitted for ONCC/ILNA approval.
ACPE Accreditation Statement
The University of Texas at Austin College of Pharmacy Continuing Professional Development will provide the ACPE accreditation for this course. The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
ACPE Credit Designation Statement
To be announced.
Privacy Policy
Personal information and data sharing: Research To Practice aggregates deidentified user data for program-use analysis, program development, activity planning and site improvement. We may provide aggregate and deidentified data to third parties, including commercial supporters. We do not share or sell personally identifiable information to any unaffiliated third parties or commercial supporters. Please see our privacy policy at ResearchToPractice.com/Privacy-Policy for more information.
Unlabeled/Unapproved Uses Notice
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the provider or grantors.
Content Validation and Disclosures
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education and adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited continuing education activity, including faculty, planners, reviewers and others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships will have been mitigated prior to the commencement of this activity. In addition, all activity content is reviewed by RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Faculty disclosures to be provided.
FACULTY
To be announced.
MODERATOR
Dr Love is president and CEO of Research To Practice. Research To Practice receives funds in the form of educational grants to develop CME activities from the following companies: Aadi Bioscience, AbbVie Inc, ADC Therapeutics, Agendia Inc, Alexion Pharmaceuticals, Amgen Inc, Array BioPharma Inc, a subsidiary of Pfizer Inc, Arvinas, Astellas, AstraZeneca Pharmaceuticals LP, Aveo Pharmaceuticals, Bayer HealthCare Pharmaceuticals, BeOne, Biotheranostics Inc, A Hologic Company, Black Diamond Therapeutics Inc, Blueprint Medicines, Boehringer Ingelheim Pharmaceuticals Inc, Bristol Myers Squibb, Catalyst Pharmaceuticals Inc, Celcuity, Clovis Oncology, Coherus BioSciences, Corcept Therapeutics Inc, CTI BioPharma, a Sobi Company, Daiichi Sankyo Inc, Eisai Inc, Elevation Oncology Inc, Exact Sciences Corporation, Exelixis Inc, Genentech, a member of the Roche Group, Genmab US Inc, Geron Corporation, Gilead Sciences Inc, GSK, Helsinn Therapeutics (US) Inc, ImmunoGen Inc, Incyte Corporation, Ipsen Biopharmaceuticals Inc, Jazz Pharmaceuticals Inc, Johnson & Johnson, Karyopharm Therapeutics, Kite, A Gilead Company, Kura Oncology, Legend Biotech, Lilly, MEI Pharma Inc, Merck, Mersana Therapeutics Inc, Mirati Therapeutics Inc, Mural Oncology Inc, Natera Inc, Novartis, Novartis Pharmaceuticals Corporation on behalf of Advanced Accelerator Applications, Novocure Inc, Nuvalent, Nuvation Bio Inc, Pfizer Inc, Pharmacyclics LLC, an AbbVie Company, Puma Biotechnology Inc, Regeneron Pharmaceuticals Inc, Revolution Medicines Inc, Rigel Pharmaceuticals Inc, R-Pharm US, Sanofi, Seagen Inc, Servier Pharmaceuticals LLC, SpringWorks Therapeutics Inc, Stemline Therapeutics Inc, Sumitomo Pharma America, Summit Therapeutics, Syndax Pharmaceuticals, Taiho Oncology Inc, Takeda Pharmaceuticals USA Inc, TerSera Therapeutics LLC, Tesaro, A GSK Company, and Verastem Inc.
Research To Practice CME/NCPD/ACPE Planning Committee Members, Staff and Reviewers
Planners, scientific staff and independent reviewers for Research To Practice have no relevant financial relationships to disclose.
The Ritz-Carlton Orlando, Grande Lakes
4012 Central Florida Pkwy
Orlando, FL 32837
Hotel Phone: (407) 206-2400
Meeting Room
Ritz Carlton Ballroom (Salons I-III) — Lobby Level
Room Reservations
A special discounted room rate of $429 per night and a discounted resort fee of $40 per night, plus applicable taxes, are available to conference attendees at The Ritz-Carlton Orlando, Grande Lakes.
Instructions on how to secure hotel accommodations will be included in the confirmation email after you have completed registration. Florida Cancer Specialists members, please contact FCS directly to confirm accommodations.
Room reservations must be made by Wednesday, March 24, 2027. A limited number of rooms are available, and we encourage you to make your reservations early. After Wednesday, March 24th, the hotel will offer the best rates based on room availability.
Parking
Discounted valet parking is available at $46.40 plus applicable taxes:
- Overnight guests: The discounted rate will be automatically applied at checkout for attendees staying within the conference hotel block.
- Daily guests: Vouchers will be provided at the registration desk each day of the conference.
Self-parking is not available at the hotel.
All parking rates are subject to change.
Program slides will be made available prior to the start of the session.
Registration to attend virtually is open to all professionals.
Please click the link to register for this live event directly on Zoom. Once you register, Zoom will send a confirmation email with your individual link to access the event. Please keep that confirmation email handy. If you do not receive it, contact our support team at meetings@researchtopractice.com.
This activity has been designed to meet the educational needs of medical oncologists, hematologists, hematology-oncology fellows, surgeons, radiation oncologists, pharmacists, nurse practitioners, clinical nurse specialists and other healthcare professionals involved in the treatment of cancer.
No registration fee is charged for this event. Preregistration is required as seating is limited.
At this time, in-person registration for this educational activity is limited to practicing clinicians. For all other professionals,* we are unable to confirm seating at this time. If you would like to be added to our standby list, please click here to complete the Standby Registration form. We will notify you should seats become available.
Virtual registration is open to all professionals. Please complete the Webcast Registration form to register for virtual attendance.
* Individuals employed by for-profit organizations, including financial institutions and biotech or pharmaceutical companies.
To ensure seating and meal service, please check in at our onsite registration desk before the start of the meeting. We cannot guarantee seating after the start of the program.
Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings.
Research To Practice fully complies with the legal requirements of the ADA. If you require any physical, dietary or other accommodations, please call us at (800) 233-6153 before the event.
If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153.
Thank you for your interest. At this time registration to attend this activity in person is closed to industry professionals and nonclinicians. Please provide your contact information below if you would like to be notified should seats become available, and we will be happy to alert you. If you have any further questions, please contact us at Meetings@ResearchToPractice.com.